Related Experiment Video

Updated: Jun 14, 2025

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.2K

Case Report: C-reactive protein apheresis in non-ST-elevation ACS-case series from the C-reactive protein apheresis

J Torzewski1, S Mattecka2, F Esposito3

  • 1Cardiovascular Center Oberallgaeu-Kempten, Clinic Association Allgaeu, Kempten, Germany.

Frontiers in Cardiovascular Medicine
|August 30, 2024
PubMed

Insights

C-reactive protein (CRP) apheresis, a novel treatment, was successfully applied for the first time in non-ST-elevation acute coronary syndrome (NSTE-ACS) patients. This innovative therapy was well-tolerated and showed promising results in managing high CRP levels in these individuals.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Inflammation Biomarkers

Background:

  • C-reactive protein (CRP) is a key inflammatory marker in acute coronary syndromes.
  • CRP apheresis has demonstrated efficacy in ST-elevation myocardial infarction and cardiogenic shock.
  • The role of CRP apheresis in non-ST-elevation acute coronary syndrome (NSTE-ACS) remains largely unexplored.

Keywords:
C-reactive protein apheresisacute coronary syndromeanti-inflammatory therapyinflammationnon-ST-elevation ACS

More Related Videos

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.2K

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
68
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
119